Home›Stocks›BBOT

BBOT — structural market context

BridgeBio Oncology Therapeutic

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 14. Each line shows the earlier value, the later value and their dates.

Price

Close $2.90 (Oct 14) vs $2.95 (Oct 13): −1.53%.

Volume

0.73× its 20-session average (601K) on Oct 14.

Includes pre- and post-market trading.

Short interest

Short interest 3.4M shares (settlement Sep 30) vs 3.6M (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 1–Sep 14, published Sep 30): 3 days with fails, largest 12K shares on Sep 3.

Previous file (settlements Aug 17–Aug 31, published Sep 16): 6 days with fails, largest 81K shares on Aug 28.

No new publication in this window.

Analyst rating actions

None recorded in this window.

Insider filings (Form 4)

None recorded in this window.

BBOT short interest & days to cover

SHARES SHORT

3.4M

% OF FLOAT

—

DAYS TO COVER

5.4

CHANGE VS PRIOR

-6.2%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (18d ago)

BBOT fails-to-deliver (FTD)

Settlement date	Failed shares	Price
2026-09-21 · 27d	2K	$4.77
2026-09-18 · 30d	4	$4.89
2026-09-17 · 31d	8K	$4.76

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

BBOT offering filings (SEC)

1 SEC filing in the last 90 days, by filing date.

Filed	Form	Document
2026-09-01	Registration statement (Form S-3) S-3	View on sec.gov ↗

2026-09-01View on sec.gov ↗
Registration statement (Form S-3) S-3

See all filings on SEC EDGAR ↗

SEC filings listed by filing date. A registration statement or prospectus does not by itself show that any shares were sold, how many, or at what price. Some of these filings cover debt securities or resales by existing holders. A filing is made by the issuer and appears under each of its tickers. Source: SEC EDGAR daily index; each filing links to its page on sec.gov.

Source: SEC EDGAR daily index, read once a day after the SEC publishes it (around 10:30 pm ET). Forms covered: S-1, S-3, F-1 and F-3 with their amendments, S-3ASR, F-3ASR, 424B4 and 424B5. · as of 2026-10-16

BBOT analyst ratings

Firm	Action	Rating	Published
Raymond James	hold	Outperform	2026-09-09
Raymond James	price_target	—	2026-09-09
Stifel Nicolaus	price_target	—	2026-09-09
Canaccord Genuity	price_target	—	2026-09-09

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

What are the SEC offering filings listed for BBOT?

They are registration statements (Forms S-1, S-3, F-1 and F-3, with their amendments and the S-3ASR and F-3ASR automatic shelf forms) and prospectuses filed under Rule 424(b)(4) or 424(b)(5). In the last 90 days the issuer of BBOT filed 1; the most recent was a registration statement (Form S-3) on 2026-09-01. A registration statement or prospectus does not by itself show that any shares were sold, how many, or at what price, and some of these filings cover debt securities or resales by existing holders.

What do analysts say about BBOT?

The most recent action: Raymond James hold to Outperform on 2026-09-09. Rating actions are shown as published by the firms; they are not graded here.

Is this page telling me to buy or sell BBOT?

No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.

All covered stocks Short Interest & FTD tracker Insider Buying tracker The platform

More tickers starting with B

B · Barrick Mining Corporation BAM · Brookfield Asset Management Lt BAND · Bandwidth Inc.BBNX · Beta Bionics, Inc.BE · Bloom Energy Corporation BEAM · Beam Therapeutics Inc.All B →

BBOT: the full history

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.